Literature DB >> 3994027

Hypoxic pulmonary vasoconstriction in the human lung: effect of repeated hypoxic challenges during anesthesia.

L Bindslev, A Jolin, G Hedenstierna, S Baehrendtz, J Santesson.   

Abstract

Six patients, ages 29-58 yr, were investigated during barbiturate and fentanyl anesthesia. After intubation with a double-lumen bronchial catheter, one lung was ventilated continuously with 100% O2, and the other was rendered hypoxic during three 15-min periods by ventilation with 95% N2 + 5% O2, with intervening 15-min periods of oxygen ventilation. Cardiac output was determined by thermodilution, and the distribution of blood flow between the lungs was assessed from the excretion of a continuously infused poorly soluble gas (SF6). The first hypoxic challenge resulted in a 10% increase in cardiac output (QT) and a reduction in the fractional perfusion of the test lung from 57% to 31% of QT. The pulmonary artery mean pressure increased by 54%, and the vascular resistance of the test lung increased threefold. The venous admixture increased from 19% to 40% of QT, whereas the inert gas shunt remained unaltered at 15% (inert gases also being eliminated by nitrogen-ventilated areas). The arterial oxygen tension decreased from 353 mmHg to 79 mmHg. On resumption of the control state, central hemodynamics and gas exchange returned to the initial values. The second and third hypoxic challenges resulted in reductions in the fractional perfusion of the test lung to 35% and 37% of QT. All other variables were altered to the same degree as during the first challenge. The authors conclude that hypoxic challenge of one lung in an intravenously anesthetized human subject elicits a maximum vasoconstrictor response within the first 15 min, and this response cannot be potentiated by repeated challenges.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3994027     DOI: 10.1097/00000542-198505000-00014

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  3 in total

1.  Methylprednisolone attenuates hypoxic pulmonary vasoconstriction in man.

Authors:  L J Bjertnaes; J Vaage
Journal:  Intensive Care Med       Date:  1996-07       Impact factor: 17.440

2.  Bacillus anthracis edema toxin inhibits hypoxic pulmonary vasoconstriction via edema factor and cAMP-mediated mechanisms in isolated perfused rat lungs.

Authors:  Xizhong Cui; Jeffrey Wang; Yan Li; Zoe G Couse; Thomas F Risoleo; Mahtab Moayeri; Stephen H Leppla; Daniela Malide; Zu-Xi Yu; Peter Q Eichacker
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-10-16       Impact factor: 4.733

3.  Repeated intermittent hypoxic stimuli to operative lung reduce hypoxemia during subsequent one-lung ventilation for thoracoscopic surgery: A randomized controlled trial.

Authors:  Susie Yoon; Bo Rim Kim; Se-Hee Min; Jaehun Lee; Jae-Hyon Bahk; Jeong-Hwa Seo
Journal:  PLoS One       Date:  2021-04-15       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.